首页> Journal of the American Society of Nephrology : JASN> Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD.

Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD.

导出 OA

翻译打印收藏纠错

第一作者： Kausik,Umanath

第一单位： Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, Michigan; kumanat1@hfhs.org.

作者： Kausik,Umanath ^[1] ; Diana I,Jalal ^[2] ; Barbara A,Greco ^[3] ; Ebele M,Umeukeje ^[4] ; Efrain,Reisin ^[5] ; John,Manley ^[6] ; Steven,Zeig ^[7] ; Dana G,Negoi ^[8] ; Anand N,Hiremath ^[9] ; Samuel S,Blumenthal ^[10] ; Mohammed,Sika ^[4] ; Robert,Niecestro ^[11] ; Mark J,Koury ^[12] ; Khe-Ni,Ma ^[13] ; Tom,Greene ^[13] ; Julia B,Lewis ^[4] ; Jamie P,Dwyer ^[4] ; Collaborative Study Group

作者单位： Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, Michigan; kumanat1@hfhs.org. ^[1] Renal Diseases and Hypertension, University of Colorado, Denver, Colorado; ^[2] Western New England Renal and Transplant Associates, Baystate Medical Center, Springfield, Massachusetts; ^[3] Divisions of Nephrology and Hypertension and. ^[4] Section of Nephrology and Hypertension, Louisiana State University Health Science Center, New Orleans, Louisiana; ^[5] Mountain Kidney and Hypertension Associates, Asheville, North Carolina; ^[6] Pines Clinical Research, Pembroke Pines, Florida; ^[7] Division of Nephrology, University of Vermont, Burlington, Vermont; ^[8] Nephrology and Hypertension Clinic, Southgate, Michigan; ^[9] Division of Nephrology, Medical College of Wisconsin, Milwaukee, Wisconsin; ^[10] Independent Consultant, Pocono Pines, Pennsylvania; and. ^[11] Hematology and Oncology, Vanderbilt University Medical Center, Nashville, Tennessee; ^[12] Department of Population Health Sciences, University of Utah, Salt Lake City, Utah. ^[13]

关键词 ESA ESRD anemia dialysis erythropoietin ferric citrate iron phosphate binder